Korro Bio Inc — Quarterly Cash Flow (NASDAQ:KRRO) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 243.54 M226.24 M202.21 M180.43 M161.55 M Total liabilities 63.91 M65.83 M63.25 M65.32 M62.52 M Total equity 179.63 M160.41 M138.96 M115.1 M99.03 M Total liabilities & shareholders' equities 243.54 M226.24 M202.21 M180.43 M161.55 M Total debt ————— Net debt —————

Haberler

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

Clear Street, hiperamnonyemi programının potansiyeli nedeniyle Korro Bio hisse senedi notunu yükseltti

Clear Street upgrades Korro Bio stock rating on hyperammonemia program potential

Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength?

H.C. Wainwright, yeni ilaç potansiyeli nedeniyle Korro Bio hisse senedi notunu Al’a yükseltti

Korro Bio stock rating upgraded by H.C. Wainwright to Buy on new drug potential

Piper Sandler, UCD tedavisi nedeniyle Korro Bio hisse senedi notunu Overweight’e yükseltti

Piper Sandler upgrades Korro Bio stock rating to Overweight on UCD treatment

Chardan Capital upgrades Korro Bio stock to Buy on KRRO-121 potential

Korro Bio, Inc. (KRRO) Analyst/Investor Day - Slideshow (NASDAQ:KRRO) 2026-01-28

William Blair, Korro Bio hissesi için Piyasa Performansı notunu yineledi

Raymond James, Korro Bio hissesi için Piyasa Performansı notunu yineledi